Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Planned sale Chief Development Officer sold 20,000 shares at $5.27 ($105,476)
  2. 4 Planned sale Chief Development Officer sold 10,272 shares at $5.00 ($51,360)
  3. 4 Planned sale Chief Development Officer sold 3,000 shares at $4.50 ($13,500)
  4. 4 Open-market sale Chief Medical Officer sold 2,581 shares at $4.36 ($11,259)
  5. 4 Open-market sale Chief Development Officer sold 3,767 shares at $4.36 ($16,432)
  6. 4 Open-market sale Chief Commercial Officer sold 4,714 shares at $4.36 ($20,563)
  7. 4 Open-market sale Chief Financial Officer sold 2,873 shares at $4.36 ($12,533)
  8. 4 Open-market sale President & CEO sold 11,368 shares at $4.36 ($49,589)
  9. 4 Open-market sale GRAMMER ELIZABETH A sold 2,384 shares at $4.36 ($10,399)
  10. 4 Open-market sale Felsch Robert Ora sold 1,044 shares at $4.36 ($4,554)
  11. 4 Open-market sale Blanks Robert sold 2,835 shares at $4.36 ($12,367)
  12. 4 Open-market sale Chief Medical Officer sold 25,000 shares at $4.00 ($99,998)
  13. 4 Planned sale Chief Development Officer sold 1,644 shares at $4.00 ($6,576)
  14. 4 Planned sale Chief Development Officer sold 2,897 shares at $4.55 ($13,181)
  15. 4 Open-market sale Chief Commercial Officer sold 4,733 shares at $3.55 ($16,811)
  16. 4 Open-market sale Chief Medical Officer sold 2,591 shares at $3.55 ($9,203)
  17. 4 Open-market sale Chief Development Officer sold 3,783 shares at $3.55 ($13,436)
  18. 4 Open-market sale Chief Financial Officer sold 2,884 shares at $3.55 ($10,243)
  19. 4 Open-market sale President & CEO sold 11,419 shares at $3.55 ($40,558)
  20. 4 Open-market sale GRAMMER ELIZABETH A sold 2,392 shares at $3.55 ($8,496)

Page 11 of 35 · 696 filings